Xia, B., Peng, W., Chen, Y., Shan, W., Jiang, W., Xiong, W. (2025). A prospective, single-arm, phase 2 trial exploring the use of pamiparib combined with surufatinib as neoadjuvant therapy for advanced, unresectable ovarian cancer (PASSION).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5589